Immediate and long-term outcomes of corticosteroid therapy in pediatric Crohn's disease patients

Inflammatory Bowel Diseases

Volumn 17, Issue 4, 2011, Pages 954-962

  Krupoves, Alfreda ^a,b   Mack, David R ^d   Seidman, Ernest G ^c   Deslandres, Colette ^a   Bucionis, Vytautas ^a   Amre, Devendra K ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Corticosteroid dependence; Corticosteroids; Crohn's disease; Outcomes; Pediatrics; Predictors

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; BUDESONIDE; CORTICOSTEROID; IMMUNOMODULATING AGENT; PREDNISONE;

AGE; ARTICLE; CANADA; CHILD; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SEX DIFFERENCE; UPPER GASTROINTESTINAL TRACT;

ANTI-INFLAMMATORY AGENTS; CANADA; CHILD; COHORT STUDIES; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952472027     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21415     Document Type: Article

References (40)

1. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916-924. (Pubitemid 29230706)
2. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559-1568. (Pubitemid 43980630)
3. Lowe AM, Roy PO, Poulin M, et al. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis. 2009;15:429-435.
4. Jakobsen C, Paerregaard A, Munkholm P, et al. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis - a population-based study from the Danish Crohn Colitis Database. Eur J Gastroenterol Hepatol. 2009; 21:1291-1301.
5. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490-1497.
6. Baumgart DC, Sandborn WJ.Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369: 1641-1657. (Pubitemid 46722637)
7. Bernstein CN, Blanchard JF, Metge C, et al. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003;98: 1797-1801. (Pubitemid 36959161)
8. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188-194. (Pubitemid 28214002)
9. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929-936. (Pubitemid 351451967)
10. Tripathi RC, Kipp MA, Tripathi BJ, et al. Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease. Lens Eye Toxic Res. 1992;9:469-482. (Pubitemid 23111717)
11. Tripathi RC, Kirschner BS, Kipp M, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology. 1992;102:1957-1961.
12. Lukert BP, Raisz LG.Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352-364. (Pubitemid 20083611)
13. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260. (Pubitemid 32729372)
14. Kim SC, Ferry GD.Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology. 2004;126:1550-1560. (Pubitemid 38649872)
15. Hyams JS, Markowitz JF.Can we alter the natural history of Crohn disease in children?J Pediatr Gastroenterol Nutr. 2005;40:262-272.
16. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000;119:895-902.
17. Markowitz J, Hyams J, Mack D, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006;4: 1124-1129. (Pubitemid 44311642)
18. Lennard-Jones JE.Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
19. Sands BE.From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology. 2004;126: 1518-1532.
20. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753. (Pubitemid 43764536)
21. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994;35: 360-362.
22. Ho GT, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24:319-330. (Pubitemid 43972900)
23. Laine L, Hanauer SB.Considerations in the management of steroid-dependent Crohn's disease. Gastroenterology. 2003;125:906-910.
24. Harvey RF, Bradshaw JM.A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
25. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
26. Zhang J, Yu KF.What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280: 1690-1691. (Pubitemid 28532993)
27. Rutgeerts P, Lofberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med. 1994;331:842-845. (Pubitemid 24289711)
28. Lichtenstein GR, Sbreu MT, Cohen R, et al. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.] Rev Gastroenterol Mex. 2006;71:351-401.
29. Valentine JF, Sninsky CA.Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol. 1999; 94:878-883. (Pubitemid 29173595)
30. Motley RJ, Clements D, Evans WD, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner. 1993;23:95-104. (Pubitemid 24028377)
31. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135:1106-1113.
32. Tung J, Loftus EV Jr, Freese DK, et al. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2006;12:1093-1100. (Pubitemid 44847465)
33. Chow DK, Sung JJ, Tsoi KK, et al. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study. Aliment Pharmacol Ther. 2009;29: 843-854.
34. Weiss B, Lebowitz O, Fidder HH, et al. Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis. Dig Dis Sci. 2009;55: 1674-1680.
35. Kiela PR, Guner YS, Xu H, et al. Age- and tissue-specific induction of NHE3 by glucocorticoids in the rat small intestine. Am J Physiol Cell Physiol. 2000;278:C629-C637. (Pubitemid 30211294)
36. Gupta N, Bostrom AG, Kirschner BS, et al. Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol. 2008;103:2092-2098.
37. Franchimont DP, Louis E, Croes F, et al. Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol. 1998;10:821-825. (Pubitemid 28493255)
38. Ewe K, Press AG, Singe CC, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology. 1993;105:367-372. (Pubitemid 23213520)
39. Yang YX, Lichtenstein GR.Corticosteroids in Crohn's disease. Am J Gastroenterol. 2002;97:803-823.
40. Brignola C, De SG, Belloli C, et al. Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther. 1994;8:465-468. (Pubitemid 24257565)